October 2, 2023

Ironshore Pharmaceuticals and CHADD to raise awareness about the negative impact of ADHD during the early morning routine

Pin It

GEORGE TOWN, Grand Cayman–(BUSINESS WIRE)–Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc., and Children and Adults with Attention-Deficit/Hyperactivity Disorder (“CHADD”), a national non-profit organization providing education, advocacy and support for individuals with ADHD, today announced an agreement whereby Ironshore will sponsor advocacy programs designed to educate parents, teachers and […]